Immunostimulation in the treatment for chronic fatigue syndrome/myalgic encephalomyelitis

By A.D. Proal  et al.

Abstract

Chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME) has long been associated with the presence of infectious agents, but no single pathogen has been reliably identified in all patients with the disease. Recent studies using metagenomic techniques have demonstrated the presence of thousands of microbes in the human body that were previously undetected and unknown to science. More importantly, such species interact together by sharing genes and genetic function within communities. It follows that searching for a singular pathogen may greatly underestimate the microbial complexity potentially driving a complex disease like CFS/ME. Intracellular microbes alter the expression of human genes in order to facilitate their survival. We have put forth a model describing how multiple species – bacterial, viral, and fungal – can cumulatively dysregulate expression by the VDR nuclear receptor in order to survive and thus drive a disease process. Based on this model, we have developed an immunostimulatory therapy that is showing promise inducing both subjective and objective improvement in patients suffering from CFS/ME.

SourceImmunol Res. 2013 Apr 11. [Epub ahead of print]. Proal AD, Albert PJ, Marshall TG, Blaney GP, Lindseth IA. Autoimmunity Research Foundation, 3423 Hill Canyon Ave, Thousand Oaks, CA, 91360, USA.

1 Star2 Stars3 Stars4 Stars5 Stars (6 votes, average: 4.65 out of 5)
Loading...



One thought on “Immunostimulation in the treatment for chronic fatigue syndrome/myalgic encephalomyelitis”

  1. Sandy10m says:

    Here is a general summary of the article. First, these authors believe that CFS and other disease processes are caused by a combination of infections that interplay with each other and your body. This may be why CFS has such a broad range of symptom sets. However, the bottom line is that some CFS patients have VDR (Vitamin D3 receptor) dysregulation. VDR is a 1,25 dihydroxyvitamin D3-activated member of the nuclear receptor superfamily of transcription factors. The diseases manipulate the Vit D3 receptors on cells and interfere with the use of Vit D3. Your blood tests may show a low level of 25-D in your blood (the raw material to make 1,25-D) but a high level of 1,25-D (the immediately usable form). One treatment that they are using in this paper is stimulating the immune system to respond. They use Olmesartan to do this. The patients will usually feel much worse for a long time, but then they slowly start to feel better, and some are cured. If you fall into this category of CFS, you might want to talk to your doctor about this treatment.

Leave a Reply